Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002

Despite advances in conventional chemotherapy, surgical techniques, and radiation, outcomes for patients with relapsed, refractory, or metastatic soft tissue sarcomas are dismal. Survivors often suffer from lasting morbidity from current treatments. New targeted therapies with less toxicity, such as...

Full description

Bibliographic Details
Published in:Molecular Therapy: Oncolytics
Main Authors: Eric K. Ring, Rong Li, Blake P. Moore, Li Nan, Virginia M. Kelly, Xiaosi Han, Elizabeth A. Beierle, James M. Markert, Jianmei W. Leavenworth, G. Yancey Gillespie, Gregory K. Friedman
Format: Article
Language:English
Published: Elsevier 2017-12-01
Online Access:http://www.sciencedirect.com/science/article/pii/S2372770517300372